Can genetically engineered bacteria prevent tooth decay? A small biotechnology company is about to take the first step toward answering that question.
The company, Oragenics, has applied to the US Food and Drug Administration to conduct the first clinical trial in which genetically modified bacteria will be put into people's mouths.
The new bacteria, which are genetically neutered so they do not make the acid that eats away at teeth, would be designed to replace the acid-producing bacteria already present in most mouths.
"The idea is simply to use good bacteria to fight bad bacteria," said Jeffrey Hillman, the chief scientific officer at Oragenics, based in Alachua, Florida.
Hillman says that if it all works as planned, people may eventually receive a single painless five-minute treatment: A dentist would rub the bacteria on their teeth, and the patients would be protected from cavities for life.
There is still a long way to go to prove the treatment's effectiveness, however. The first trial, which the company said it hoped to start as soon as next month, will be a small test of safety, not effectiveness in fighting cavities.
Still, even getting to this point has been a challenge. Hillman has been working on this therapy for 25 years and first applied to the FDA for permission to begin a clinical trial in 1998. The agency, the company said, has demanded change upon change to make sure the modified bacteria will not run amok, cause undesirable changes in the mouth or revert to a cavity-producing form.
To win approval, Oragenics has agreed that the 15 volunteers in the first trial will not even have teeth -- they will have dentures. That way, if something unexpected happens, the dentures can be plopped into bleach to exterminate the microbes, which mainly stick to teeth.
"The FDA has its failsafe," said Chuck Soponis, the chief executive of Oragenics. A spokeswoman for the FDA said the agency was not allowed to discuss clinical trials under its purview.
Oragenics' approach, which it calls replacement therapy, is part of a broader movement to view tooth decay as an infectious disease, probably the world's most common one.
Now, cavities are "basically treated as a surgical problem rather than an infection problem," said Dr. Martin Taubman, head of the department of immunology at the Forsyth Institute in Boston, a private dental research organization.
Taubman is working on a vaccine that he envisions will one day be sprayed in the nostrils of 1-year-old children to protect them from the cavity-causing microbe.
Planet Biotechnology of Hayward, California, is using genetically engineered plants to make antibodies that may be able to neutralize the bacteria.
There are hundreds of species of bacteria in people's mouths, but scientists say that one, Streptococcus mutans, accounts for most tooth decay.
This strain is adept at clinging to teeth and lives on sugar, producing as a waste product lactic acid, which eats away at the minerals in teeth. Most young children get S. mutans from close contact with their mothers when their teeth start appearing.
The replacement-therapy approach is not unlike adding good bacteria to yogurt in the hopes of combating bad bacteria in the digestive tract.
To make his anticavity bacteria, Hillman, who is on leave from the University of Florida, where much of the work was done, removed the gene for lactic acid production from S. mutans.
That change killed the bacteria, because they had no way to eliminate their waste. So he added an extra copy of a gene for alcohol production, allowing the bacteria to produce extra alcohol as a waste product, though far too little, Hillman said, to have any effect on people.
Another challenge is ensuring that the modified bacteria can fend off their conventional cousins to remain in the mouth. To create his biotech bug, Hillman started with a rare but natural strain, found in about 1 percent of mouths. It makes an antibiotic that kills other S. mutans strains.
In tests on rats fed a high-sugar diet, the modified bugs reduced cavities by half. And the natural antibiotic producing the S. mutans strain did displace the more common strain in two people and persisted in their mouths for 15 years, Hillman said.
Still there are numerous questions. Will the antibiotic kill other bacteria as well, upsetting the delicate balance of species in the mouth? Will the genetically engineered bacteria spread to others, by kissing, for example?
To satisfy safety concerns, Oragenics modified the bacteria further to make them dependent on a certain amino acid that is not usually found in the human diet. To keep the bacteria alive, participants in the first clinical trial will have to use a mouthwash containing that amino acid twice a day. The company plans to eliminate that requirement in the final product.
In this trial the volunteers will have the bugs spread on their teeth with cotton swabs, and then be required to eat sugary foods to help the bacteria colonize. The biotech bacteria will be in their mouths for only seven days before they eliminate them with an antibacterial mouthwash. The trial will involve men whose spouses or partners will also be tested to see of the bacteria has spread.
The proposed trial was reviewed in March without major objections by the Recombinant DNA Advisory Committee, an advisory arm of the National Institutes of Health that screens trials involving genetically engineered organisms, particularly gene therapy tests.
Oragenics' treatment does not seem to have aroused the concern of groups that oppose genetically modified crops.
Soponis of Oragenics said that if all went well with this safety trial and future trials on effectiveness, the treatment could reach the market by 2009 or 2010.
Attracting investors and business partners, however, could be hard. Fluoride treatments, which strengthen the teeth, have reduced tooth decay sharply. And Oragenics, a publicly traded company, has only about US$4 million in cash and will need a bigger partner to get its treatment through clinical trials, Soponis said.
Replacement therapy or vaccines probably will not eliminate tooth decay completely, since there are other bacteria that make acid. And tooth brushing will still be needed, Hillman said, if only to fight bad breath and gum disease.
"I would never tell anyone not to brush their teeth," Hillman said.
But clearly people do not always brush or floss. And that, he said, leaves room for a treatment that will allow people to sit back and let genetically engineered bacteria do all the work.
ROLLER-COASTER RIDE: More than five earthquakes ranging from magnitude 4.4 to 5.5 on the Richter scale shook eastern Taiwan in rapid succession yesterday afternoon Back-to-back weather fronts are forecast to hit Taiwan this week, resulting in rain across the nation in the coming days, the Central Weather Administration said yesterday, as it also warned residents in mountainous regions to be wary of landslides and rockfalls. As the first front approached, sporadic rainfall began in central and northern parts of Taiwan yesterday, the agency said, adding that rain is forecast to intensify in those regions today, while brief showers would also affect other parts of the nation. A second weather system is forecast to arrive on Thursday, bringing additional rain to the whole nation until Sunday, it
CONDITIONAL: The PRC imposes secret requirements that the funding it provides cannot be spent in states with diplomatic relations with Taiwan, Emma Reilly said China has been bribing UN officials to obtain “special benefits” and to block funding from countries that have diplomatic ties with Taiwan, a former UN employee told the British House of Commons on Tuesday. At a House of Commons Foreign Affairs Committee hearing into “international relations within the multilateral system,” former Office of the UN High Commissioner for Human Rights (OHCHR) employee Emma Reilly said in a written statement that “Beijing paid bribes to the two successive Presidents of the [UN] General Assembly” during the two-year negotiation of the Sustainable Development Goals. Another way China exercises influence within the UN Secretariat is
CHINA REACTS: The patrol and reconnaissance plane ‘transited the Taiwan Strait in international airspace,’ the 7th Fleet said, while Taipei said it saw nothing unusual The US 7th Fleet yesterday said that a US Navy P-8A Poseidon flew through the Taiwan Strait, a day after US and Chinese defense heads held their first talks since November 2022 in an effort to reduce regional tensions. The patrol and reconnaissance plane “transited the Taiwan Strait in international airspace,” the 7th Fleet said in a news release. “By operating within the Taiwan Strait in accordance with international law, the United States upholds the navigational rights and freedoms of all nations.” In a separate statement, the Ministry of National Defense said that it monitored nearby waters and airspace as the aircraft
Taiwan’s first drag queen to compete on the internationally acclaimed RuPaul’s Drag Race, Nymphia Wind (妮妃雅), was on Friday crowned the “Next Drag Superstar.” Dressed in a sparkling banana dress, Nymphia Wind swept onto the stage for the final, and stole the show. “Taiwan this is for you,” she said right after show host RuPaul announced her as the winner. “To those who feel like they don’t belong, just remember to live fearlessly and to live their truth,” she said on stage. One of the frontrunners for the past 15 episodes, the 28-year-old breezed through to the final after weeks of showcasing her unique